Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Medesis Pharma SA (ALMDP)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.25 +0.01    +0.40%
11:39:21 - Real-time Data. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  France
ISIN:  FR0010844464 
  • Volume: 232
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 1.25 - 1.27
Medesis Pharma 1.25 +0.01 +0.40%

Medesis Pharma SA Company Profile

 
Get an in-depth profile of Medesis Pharma SA, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

-

Equity Type

ORD

Medesis Pharma SA is a France-based clinical development stage biopharmaceutical Company. The Company is engaged through its drug delivery technology Aonys in the development of orally administered molecule drug candidates to expand their therapeutic usefulness to address unmet medical needs. Its technology is also being used for collaborative research programs focused on oncology (customized cancer treatment) and radiotherapy (protection of healthy tissue). The Company’s two drug candidates for treating people contaminated following a civil or military nuclear accident are Plutonium decorporation and Cesium decorporation.

Contact Information

Address L’Orée des Mas Bât. Les Cyprès
Avenue du Golf Baillargues Montpellier, 34670
France
Phone 33 4 67 03 03 96
Fax -

Top Executives

Name Age Since Title
Cedric Navas - 2021 Member of the Supervisory Board
Sylvie Mader - - Member of International Scientific Advisory Board - Oncology
Olivier Connes - 2021 Chairman of the Supervisory Board
Jean-Marie Cazaledes - 2021 Member of the Supervisory Board
Serge Gauthier - - Member of International Scientific Advisory Board - Neuro-Psychiatry
Gerald Batist - - Member of International Scientific Advisory Board - Oncology
Jacques Touchon - - Member of International Scientific Advisory Board - Neuro-Psychiatry
Jean-Philippe Causse - 2021 Member of the Supervisory Board
Claudio Cuello - - Member of International Scientific Advisory Board - Neuro-Psychiatry
Paul Loubet - - Member of International Scientific Advisory Board - Infectious diseases
Guy A. Rouleau - - Member of International Scientific Advisory Board - Neuro-Psychiatry
Bernard Connes - 2021 Vice-Chairman of the Supervisory Board
George Lyketsos - 2023 Member of Scientific Advisory Board
Cecilia Marelli - 2023 Member of Scientific Advisory board
Edward N. Wilson - 2023 Member of Scientific Advisory Board
Maria Soto Martin - 2023 Member of Scientific Advisory board
Zahinoor Ismail - 2023 Member of Scientific Advisory Board
Mahmoud Pouladi - 2023 Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ALMDP Comments

Write your thoughts about Medesis Pharma SA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email